Dashboard
Manage Tickers

REPL Replimune Group, Inc.

Nasdaq replimune.com


$ 10.30 $ -0.24 (-2.3 %)    

Wednesday, 29-Oct-2025 18:34:08 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 10.21
$ 10.36
$ 9.80 x 20
$ 10.62 x 30
$ 9.96 - $ 10.61
$ 2.68 - $ 17.00
2,494,497
na
796.95M
$ 0.85
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-22-2025 03-31-2025 10-K
3 02-12-2025 12-31-2024 10-Q
4 11-12-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-16-2024 03-31-2024 10-K
7 02-08-2024 12-31-2023 10-Q
8 11-07-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-18-2023 03-31-2023 10-K
11 02-09-2023 12-31-2022 10-Q
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-19-2022 03-31-2022 10-K
15 02-03-2022 12-31-2021 10-Q
16 11-04-2021 09-30-2021 10-Q
17 08-06-2021 06-30-2021 10-Q
18 05-20-2021 03-31-2021 10-K
19 02-04-2021 12-31-2020 10-Q
20 11-05-2020 09-30-2020 10-Q
21 08-07-2020 06-30-2020 10-Q
22 06-03-2020 03-31-2020 10-K
23 02-13-2020 12-31-2019 10-Q
24 11-12-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 06-28-2019 03-31-2019 10-K
27 02-14-2019 12-31-2018 10-Q
28 11-14-2018 09-30-2018 10-Q
29 08-30-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-five-below-analyst-turns-bullish-here-are-top-5-upgrades-for-monday
This Five Below Analyst Turns Bullish; Her...
10/27/2025 11:29:57

hc-wainwright--co-upgrades-replimune-group-to-buy-announces-12-price-target
HC Wainwright & Co. Upgrades Replimune Gro...
10/27/2025 11:21:03

HC Wainwright & Co. analyst Robert Burns upgrades Replimune Group (NASDAQ:REPL) from Neutral to Buy and announces $12 pr...

jp-morgan-upgrades-replimune-group-to-neutral-announces-11-price-target
JP Morgan Upgrades Replimune Group to Neut...
10/20/2025 22:01:07

JP Morgan analyst Anupam Rama upgrades Replimune Group (NASDAQ:REPL) from Underweight to Neutral and announces $11 price tar...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/20/2025 18:39:30

heres-why-replimune-group-repl-stock-is-up-over-100-today
Here's Why Replimune Group (REPL) Stock Is...
10/20/2025 16:14:07

Shares of Replimune Group are rising Monday after the clinical stage biotechnology company shared an important regulatory update.

leerink-partners-upgrades-replimune-group-to-outperform-raises-price-target-to-13
Leerink Partners Upgrades Replimune Group ...
10/20/2025 14:35:25

Leerink Partners analyst Jonathan Chang upgrades Replimune Group (NASDAQ:REPL) from Market Perform to Outperform and raises ...

ww-international-replimune-group-datavault-ai-grail-and-other-big-stocks-moving-higher-on-monday
WW International, Replimune Group, Datavau...
10/20/2025 14:13:22

dow-jumps-over-200-points-cleveland-cliffs-shares-jump-after-q3-results
Dow Jumps Over 200 Points; Cleveland-Cliff...
10/20/2025 13:49:54

wedbush-upgrades-replimune-group-to-outperform-raises-price-target-to-18
Wedbush Upgrades Replimune Group to Outper...
10/20/2025 13:09:45

Wedbush analyst Robert Driscoll upgrades Replimune Group (NASDAQ:REPL) from Neutral to Outperform and raises the price targe...

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
10/20/2025 12:08:17

Core News & Articles
Market-Moving News for October 20th
10/20/2025 11:36:19

REPL: 81% | The FDA Accepts Replimune's Resubmission Of The Biologics License Application For RP1 In Combination With Nivol...

the-fda-accepts-replimunes-resubmission-of-the-biologics-license-application-for-rp1-in-combination-with-nivolumab-for-advanced-melanoma-pdufa-date-is-april-10-2026
The FDA Accepts Replimune's Resubmission O...
10/20/2025 11:07:36

replimune-group-option-alert-oct-17-6-calls-sweep-16-near-the-ask-1346--025-vs-129-oi
Replimune Group Option Alert: Oct 17 $6 Ca...
09/29/2025 18:27:43

this-united-parcel-service-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-friday
This United Parcel Service Analyst Is No L...
09/19/2025 12:06:21

jp-morgan-downgrades-replimune-group-to-underweight
JP Morgan Downgrades Replimune Group to Un...
09/19/2025 11:39:42

JP Morgan analyst Anupam Rama downgrades Replimune Group (NASDAQ:REPL) from Neutral to Underweight.

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 17:06:02

gold-falls-over-1-darden-posts-downbeat-earnings
Gold Falls Over 1%; Darden Posts Downbeat ...
09/18/2025 16:27:56

nasdaq-surges-100-points-bionano-genomics-shares-plunge
Nasdaq Surges 100 Points; Bionano Genomics...
09/18/2025 13:59:31

replimune-group-completes-type-a-meeting-with-fda-on-rp1-bla-for-advanced-melanoma-path-forward-for-accelerated-approval-still-undetermined
Replimune Group Completes Type A Meeting W...
09/18/2025 13:19:19

Replimune Group, Inc. (NASDAQ:REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immun...

hc-wainwright--co-reiterates-neutral-on-replimune-groupto-neutral
HC Wainwright & Co. Reiterates Neutral on ...
09/08/2025 12:14:40

HC Wainwright & Co. analyst Robert Burns reiterates Replimune Group (NASDAQ:REPL) from Neutral to Neutral.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION